Are bees dangerous? What to know after multiple cases of bee attacks
Members of a since-relocated hive attacked locals over the course of about 30 minutes, Mayor Pierre Mathonier told local news outlets, and sent three people to the hospital, including a 78-year-old man who went into cardiac arrest before being revived, AP reported.
The attack is believed to have been prompted by the presence of Asian hornets, sometimes nicknamed "murder hornets," an invasive species that also has a growing presence in the U.S.
The good news is that swarming bee attacks of this severity are rare. Bees and wasps, like plenty of other wildlife, are not known to be particularly aggressive toward humans and generally only attack if their hive has been threatened.
While bees and wasps are generally not a risk to people (in fact, their dwindling numbers are a bigger risk to humans as a whole, thanks to the vital role they play in our ecosystem and food chain), stories like the attack out of France are enough to inspire some measure of anxiety.
Are bees a potentially deadly danger Americans contend with each time they step out the door? Here's what to know.
While only an average of 72 Americans died from hornet, wasp and bee stings each year between 2011 and 2021, according to the Centers for Disease Control and Prevention, it can and does happen, especially in the spring and summer months when North American hives tend to be the most active.
Several major bee attacks have been reported in multiple U.S. states in 2025 alone.
On Sunday, July 7, bees stung members of a crew working on a nursing home roof in Arizona, killing one and seriously harming two others.
In May, a 66-year-old Texas man was killed when a swarm of bees stung him enough times to cause his circulatory system to stop functioning properly. Just weeks before, another Texas resident was attacked by a massive throng that killed three of her horses.
Generally speaking, bees and wasps aren't aggressive simply for the sake of being aggressive, according to the Cleveland Clinic. Like most creatures with natural predators, bees have developed mechanisms to protect themselves and their nests. If they perceive humans as a threat, whether that be due to swatting them or disturbing their nest, they may sting as a defense mechanism to ward the threat off.
Some bees also release a type of "warning" or "danger" pheromone when they sting that attracts other bees to the fight against the perceived threat at hand, like summoning a small insect army.
To avoid drawing the ire of a nest, be aware of your surroundings and avoid nests and swatting at bees hanging out nearby, suggests Mayo Clinic. Cover food when eating outside, avoid floral-smelling colognes and perfumes and wear protective clothing like long sleeves and pants when working or playing outdoors.
If you find yourself at the top of a bee or wasp swarm's public enemy list, stay calm and get out of the area quickly.
Your best bet is to run to the nearest shelter, suggests an advisory from the University of Arizona, and keep running until you get there. Protect your face, especially your mouth and eyes, by covering the area with whatever you have on hand – a mask, handkerchief, coat, towel, hat or, as a last resort, your shirt could work.
Do not try to freeze, play dead or jump into a body of water, the advisory says.
The most common cause of serious illness or death from bee stings is an allergic reaction called anaphylaxis. An anaphylactic reaction affects your skin, airways, stomach and heart, per the Cleveland Clinic.
Although this will vary from person to person, initial symptoms are typically characterized by hives, swelling or edema and breathing difficulties. As symptoms progress, you may begin to experience "tightness in the chest, shortness of breath, coughing, wheezing, and then swelling of the face to tongue and lips and eyes," Dr. Payel Gupta, medical director of Allergy, Asthma and Immunology at LifeMD, previously told USA TODAY. If left untreated, anaphylaxis can be fatal.
Epinephrine is a life-saving medication used to treat anaphylaxis, and it is injected as a shot in your thigh, according to the Mayo Clinic. Anaphylaxis can happen within seconds, which is why it's so important to call 911 and seek medical care at the onset of symptoms, Gupta said.
In some cases, victims of bee attacks can die without having a known allergy, especially if they receive an excessive number of stings. Stings contain venom, which usually can be fought off by the body fairly easily.
However, being stung dozens of times can make anyone feel sick as their body works to handle the venom and, in the exceedingly rare case that someone is stung hundreds or even thousands of times, the venom may be enough to cause serious illness or even death, according to the Mayo Clinic.
People who are not allergic but have been stung multiple times should still seek medical attention, says the Mayo Clinic, and children or those who have existing respiratory issues are especially at risk for an adverse reaction to a larger number of stings.
This article originally appeared on USA TODAY: Are bees deadly? What to know after recent bee attacks
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Aegis Capital Reaffirms Buy on Atai Life Sciences N.V. (ATAI) with $8 Target
Atai Life Sciences N.V. (NASDAQ:ATAI) is among the . Aegis Capital analysts have reaffirmed their Buy rating on Atai Life Sciences N.V. (NASDAQ:ATAI), with an unchanged price target of $8.00, following the favorable Phase 2b results of the BPL-003 treatment for the company's Treatment Resistant Depression (TRD). Around 193 depression patients, who didn't respond to previous treatment, were part of the Phase 2b trial testing three doses: 0.3 mg, 8 mg, and 12 mg. Not only the 8mg but also the 12mg dose showcased statistically significant improvement in an FDA-accepted measurement of depression, with a healthy side-effect profile. A close-up of a medical professional providing advice to a patient struggling with opioid use disorder. The research firm believes these robust results strengthen the company's efforts to proceed to a Phase 3 clinical program, which would result in marketing approval. Going forward, Atai Life Sciences N.V. (NASDAQ:ATAI) plans to schedule a post-Phase 2 meeting with the FDA, with the Phase 3 trial expected to begin only at the end of the upcoming year. Another noteworthy development is the company's recent $50 million private capital raise, which involved the sale of 18,264,840 common shares with 25% warrant coverage at the market price. Moves like these highlight Atai Life Sciences N.V. (NASDAQ:ATAI)'s capacity to raise cash when needed. Atai Life Sciences N.V. (NASDAQ:ATAI) is a German clinical-stage biopharmaceutical company that researches, develops, and markets mental health treatments in the United States, Germany, and Canada. With a market capitalization of $587.639 million, the company is committed to healing mental health disorders. While we acknowledge the potential of ATAI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Yahoo
8 hours ago
- Yahoo
The Best Exercise for Your Personality Type, According to a New Study
Reviewed by Dietitian Alyssa Pike, RDNMaking exercise a regular habit can be difficult for many people. A new study suggests that tailoring it to your personality might help. You're more likely to make exercise a habit if you enjoy doing new habits is hard (to say the least). It takes mindset work and consistent practice to make any new habit stick. But there are a few tricks that can be employed to help make the process easier—like working out according to your personality type. Researchers from the United Kingdom sought to determine whether certain personality types were more drawn to or enjoyed specific intensities of exercise. They published their findings in Frontiers in Psychology. Let's break down what they found. Researchers initially recruited 132 participants from the general public for this study; 86 of the 132 completed the entire protocol. Participants first completed an online questionnaire that included demographic information, the Perceived Stress Scale 10 items (PSS-10), and a modified version of the Big Five Inventory 10 items (BFI-10). The PSS-10 is designed to assess people's perceived stress levels, and the BFI-10 is a shortened version of a longer assessment for determining personality traits. The big five personality traits assessed with the BFI-10 include extraversion, agreeableness, conscientiousness, emotional stability and openness. Emotional stability relates to neuroticism. For example, people who score high in emotional stability are considered low in neuroticism. They tend to be calm and resilient with more positive attitudes and moods. People who score low in emotional stability tend to have more neurotic traits, including anxiety, irritability and moodiness, and tend to have stronger reactions to stress. Following the online assessments, participants were brought into an exercise lab for baseline fitness testing. This included body composition, which is a measured ratio of lean tissue to fat tissue, and strength tests that included push-ups, planks and jumping in place with hands on hips. Participants' aerobic capacities were also tested on a stationary bike, first with a 'lab low-intensity' ride, and then, after a 30-minute rest, a high-intensity ride on the same bike was used to measure VO2peak. VO2peak is the highest oxygen consumption measured during an exercise test. It basically measures how efficiently your body is at using oxygen during intense exercise. After each exercise session, participants were asked to rate their level of enjoyment from 1 to 7, 1 being not enjoyable and 7 being extremely enjoyable. Following the baseline tests, participants were randomly assigned to either the intervention or control group. The control group was instructed to maintain their normal lifestyle and was given a plan of weekly 10-minute stretching exercises. The intervention group was provided with a heart rate monitor and a home-based 8-week cycling and strength training program that included 'rides' of three varying intensities—low, threshold and high-intensity interval training (HIIT). Each ride would be completed once per week for a total of three rides per week. The overall intensities gradually increased over the 8-week intervention. They were also instructed to do one strength training workout a week, which included 3 sets of 8 repetitions of squats, lunges, push-ups, sit-ups, calf raises and glute bridges. Participants were asked to rate their level of perceived enjoyment of each exercise session over the entire intervention period. Based on the pre-intervention testing: Extraversion was predictive of having higher VO2peak, anaerobic threshold and peak power output. Conscientiousness predicted completing push-ups, longer plank times, more weekly hours of physical activity and lower body fat percentage. Neuroticism predicted poorer heart rate recovery times (how quickly your heart rate comes back down to pre-exercise levels), regardless of fitness level. Those who were part of an endurance club (like a running club) were more extraverted and conscientious. Regarding exercise enjoyment: Those who scored higher in neuroticism reported less enjoyment of the low-intensity lab session and threshold ride. Extraversion predicted enjoyment of the VO2peak test and the HIIT sessions. Both openness and agreeableness predicted more enjoyment for the long, easy ride. Regarding program adherence and participation: Intervention group participants who scored higher in neuroticism were less likely to record their heart rate data during the 8-week intervention. Extraverted participants were less likely to attend post-intervention testing. Those scoring high in openness were more likely to attend post-intervention testing. The 8-week intervention revealed that: Those who scored high in neuroticism were the only ones who noted a decrease in stress from the intervention. All participants in the intervention group, regardless of personality traits, exhibited a significant increase in weekly hours of exercise, VO2peak, peak power output, number of push-ups and duration of planks. Conscientious participants showed smaller improvements in peak power output. Those with extraversion traits had a greater increase in RERpeak (respiratory exchange ratio, a measure of intensity and effort during an exercise test). There were a few limitations to this study. First, 70% of the participants were found to be open-minded, conscientious and emotionally stable, presenting some bias in the sample of participants. While this study included the Big Five personality traits, it did not consider subtraits or other personality factors, like grit or anxiety. Lastly, this study only included cycling and body weight exercises. This limits participants' responses to just those exercises. So if you already know you hate cycling, chances are you're not going to enjoy any of the variations in intensity either. This study suggests that certain personalities may enjoy certain intensities of exercise more than others. "We found some clear links between personality traits and the type of exercise the participants enjoyed most,' says Flaminia Ronca, Ph.D., one of the study authors in a press release, 'which I think is important because we could potentially use this knowledge to tailor physical activity recommendations to the individual—and hopefully help them to become and remain more active." People who scored high in either neuroticism or extraversion: Enjoyed the higher-intensity workouts more than the lower-intensity ones. Researchers note that those with neurotic tendencies may tolerate a HIIT workout better than a long, vigorous workout because the latter may allow for more anxiety, worry and negative self-talk to creep in and affect performance. People who scored high in conscientiousness: Engage in physical activity for the health benefits. They're also goal-oriented. So if they've set a goal to complete 6 months of training for a marathon, they're likely to achieve it. While research offers a glimpse into the what and why of topics, you probably don't need a personality test and a study to tell you what types of physical activity you find enjoyable. But these results do provide you with possible reasons why you might not enjoy certain types of physical activity. And you can now use your personality as the scapegoat if someone tries pushing you to do an activity you don't like. There are a few other things to consider when finding activities that you'll enjoy. For example, do you like doing things as a team or group, or are you more of an individual player? If you like doing things as a team, consider group fitness classes. Choose the type and intensity based on your personality and fitness level. Group personal training is another option. Or you can join a community sports team or running or cycling club. If you're more independent and aren't into the group thing, consider activities you can do on your own or with a friend. You may also enjoy one-on-one personal training. This study suggests that personality traits may determine which types of physical activities will be most enjoyable. Ultimately, the best types of physical activity for you are ones you'll enjoy and stick with. And while guidelines are important—like getting a minimum of 150 minutes of moderate or 75 minutes of vigorous physical activity per week—any amount of physical activity is better than none, and it all counts. Start where you're at and what you're comfortable with, and make intentional decisions to move more throughout the day, even if it's in small spurts. Over time, as your body gets used to moving more, you may naturally increase the amount. And before you know it, you'll be crushing those guidelines (in a good way). Read the original article on EATINGWELL
Yahoo
8 hours ago
- Yahoo
Lupin and Zentiva in licence and supply deal for Certolizumab Pegol
Zentiva Group has entered into a licence and supply agreement with pharmaceutical company Lupin for the commercialisation of the latter's biosimilar Certolizumab Pegol, a tumour necrosis factor alpha (TNFα) inhibitor medicine, across several markets. The partnership will enhance the availability of the affordable biosimilar on a global scale. Zentiva will manage commercial activities primarily within Europe and CIS markets, excluding the US and Canada. Meanwhile, Lupin will focus on product development, manufacturing, supply of the medicine within the agreed territories and commercial efforts in the remaining regions, including Canada and the US. The collaboration involves investment from both companies. Lupin will receive $10m upon execution of the agreement and could earn up to $50m based on developmental and regulatory milestones. Profits generated within their respective markets will be shared between Zentiva and Lupin. The biosimilar is a recombinant humanised antibody Fab' fragment targeting TNFα, conjugated to a 40kDa polyethylene glycol. Zentiva CEO Steffen Saltofte stated: "Ensuring accessibility to high-quality and affordable healthcare is at Zentiva's core. Our collaboration agreement with Lupin signifies another step forward in our biosimilars and growth strategies. 'Lupin's advanced development and manufacturing capabilities, coupled with our significant market knowledge and presence, mean we can deliver high-quality biosimilar solutions for our customers and their patients, aligning with our purpose of providing health and wellbeing for all generations." The biosimilar is indicated for conditions including rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis without X-ray evidence (non-radiographic), moderate-to-severe plaque psoriasis and Crohn's disease. Lupin president of corporate development Fabrice Egros stated: 'Our global development and commercialisation partnership with Zentiva, with its pan-European focus, enables Lupin to commercialise this unique biosimilar in its core markets and through Zentiva in Europe. 'This partnership underscores our dedication to improving the quality of life for individuals living with chronic conditions and ensuring accessibility and affordability of transformative therapies worldwide.' In March 2025, Lupin entered a licensing and supply agreement with SteinCares to commercialise its biosimilar ranibizumab in Latin American markets excluding Argentina and Mexico. "Lupin and Zentiva in licence and supply deal for Certolizumab Pegol" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.